Subscribe To Our Free Newsletter |
Ajanta Pharma spurts as Q4 PAT climbs 66% YoY, board OKs Rs 285-cr share buyback
Ajanta Pharma rallied 9.58% to Rs 2,447.05 after the company's consolidated net profit surged 65.82% to Rs 202.72 crore on 19.53% rise in revenue from operations to Rs 1,054.08 crore in Q4 FY24 over Q4 FY23.